ArticleHealth affairs (Project Hope)2019
Explaining The Slowdown In Medical Spending Growth Among The Elderly, 1999-2012.
Article in Health affairs (Project Hope), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 30 citations in OpenAlex.
- Trends in health workforce and spending growth in four countries, 2000-2023: a longitudinal analysis.BMJ open · 2026Article
- The impact of health literacy on healthcare spending: theory and evidence from China.International journal of health economics and management · 2026Article
- Medicare at 60: Suggestions for balancing access to care and financial protections with fiscal concerns.Health services research · 2025Article
- Ultrasound-Targeted β-Catenin Gene Therapy Improves the Cardiac Function in Mice After Myocardial Infarction.Cardiovascular toxicology · 2025Article
- The Polypill: A New Alternative in the Prevention and Treatment of Cardiovascular Disease.Journal of clinical medicine · 2024Review
- Medicare's hospital readmissions reduction program and the rise in observation stays.Health services research · 2023Article
- Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.Circulation · 2023Review
- Trends in and Factors Contributing to the Slowdown in Medicare Spending Growth, 2007-2018.JAMA health forum · 2022Article
- A Satellite Account for Health in the United States.The American economic review · 2022Article
- Traditional Medicare Spending on Inpatient Episodes as Hospitalizations Decline.Journal of hospital medicine · 2021Article
- Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 to 2016.Circulation · 2021Article
- Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings.CJC open · 2021Article
- Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition.The European journal of health economics : HEPAC : health economics in prevention and care · 2021Article
- Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.Circulation · 2021Article
- Financing Drug Innovation in the US: Current Framework and Emerging Challenges.PharmacoEconomics · 2020Review
- COMBINING INFORMATION FROM MULTIPLE DATA SOURCES TO ASSESS POPULATION HEALTH.Journal of survey statistics and methodology · 2020Article
- Creating an Age-Friendly Public Health System.Innovation in aging · 2020Article
- Age-friendly city: future perspectives for the Brazilian cities.Dementia & neuropsychologiaReview
- Medicare Advantage Enrollment and Total Medicare Program Spending.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 2 countries.
Funding
Abstract
We examined trends in per capita spending for Medicare beneficiaries ages sixty-five and older in the United States in the period 1999-2012 to determine why spending growth has been declining since around 2005. Decomposing spending by condition, we found that half of the spending slowdown was attributable to slower growth in spending for cardiovascular diseases. Spending growth also slowed for dementia, renal and genitourinary diseases, and aftercare for people with acute illnesses. Using estimates from the medical literature of the impact of pharmaceuticals on acute disease, we found that roughly half of the reduction in major cardiovascular events was attributable to medications controlling cardiovascular risk factors. Despite this substantial cost-saving improvement in cardiovascular health, additional opportunities remain to lower spending through disease prevention and control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.